We outline a paradigm for meta-microarray database creation and integration with clinical variables. We use as our implementation example a breast cancer database linking RNA expression measurements (by microarray) and clinical variables, such as survival metrics and tumor size. Such an endeavor involves integrating across different microarray datasets as well as clinical parameters. To this end, we created a data curation and processing pipeline, formal database ontology, and SQL schema to optimally query, analyze and visualize data from over 30 publicly available breast cancer microarray studies listed in the Gene Expression Omnibus (GEO). We demonstrate several pilot examples using this database. This methodology serves as a model for fu...
DNA microarrays have been widely used to study gene expression in human cancer. The primary analyses...
Most oncological microarray studies focus on molecular distinctions in different cancer entities. Re...
Transcriptome data provide a valuable resource for the study of cancer molecular mechanisms, but tec...
We outline a paradigm for meta-microarray database creation and integration with clinical variables....
Background In molecular profiling studies of cancer patients, experimental and clinical data are com...
Abstract Background Over the past decade, gene expression microarray studies have greatly expanded o...
The identification of novel candidate markers is a key challenge in the development of cancer therap...
The DNA microarray technology has arguably caught the attention of the worldwide life science commun...
Large public repositories of microarray experiments offer an abundance of biological data. It is of ...
The DNA microarray has revolutionized cancer research. Now, scientists can obtain a genome-wide pers...
International audienceBackgroundRecent cancer genome studies on many human cancer types have relied ...
The identification of novel candidate markers is a key challenge in the development of cancer therap...
Cancer is one of the four major non-communicable diseases (NCD), responsible for similar to 14.6% of...
The transcriptome of breast cancers have been extensively screened with microarrays and large sets o...
These datasets, which are widely used for the classification of microarray cancer data, are obtained...
DNA microarrays have been widely used to study gene expression in human cancer. The primary analyses...
Most oncological microarray studies focus on molecular distinctions in different cancer entities. Re...
Transcriptome data provide a valuable resource for the study of cancer molecular mechanisms, but tec...
We outline a paradigm for meta-microarray database creation and integration with clinical variables....
Background In molecular profiling studies of cancer patients, experimental and clinical data are com...
Abstract Background Over the past decade, gene expression microarray studies have greatly expanded o...
The identification of novel candidate markers is a key challenge in the development of cancer therap...
The DNA microarray technology has arguably caught the attention of the worldwide life science commun...
Large public repositories of microarray experiments offer an abundance of biological data. It is of ...
The DNA microarray has revolutionized cancer research. Now, scientists can obtain a genome-wide pers...
International audienceBackgroundRecent cancer genome studies on many human cancer types have relied ...
The identification of novel candidate markers is a key challenge in the development of cancer therap...
Cancer is one of the four major non-communicable diseases (NCD), responsible for similar to 14.6% of...
The transcriptome of breast cancers have been extensively screened with microarrays and large sets o...
These datasets, which are widely used for the classification of microarray cancer data, are obtained...
DNA microarrays have been widely used to study gene expression in human cancer. The primary analyses...
Most oncological microarray studies focus on molecular distinctions in different cancer entities. Re...
Transcriptome data provide a valuable resource for the study of cancer molecular mechanisms, but tec...